Dr Leanne Labriola will be leading the retina journal club this morning. Please come prepared  by reading the following journal articles.

1. eylea in wet AMd (third years). Ophthalmology. 2012 Dec;119(12):2537-48. doi: 10.1016/j.ophtha.2012.09.006. Epub 2012 Oct 17.Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration.Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y,Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups.

2. HORIZON Trial - Lucentis in Vein Occlusions (second years)m Ophthalmology. 2012 Apr;119(4):802-9. doi: 10.1016/j.ophtha.2011.12.005. Epub 2012 Feb 1. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P.

3. ASA connection to AMD (first years) JAMA. 2012 Dec 19;308(23):2469-78. doi: 10.1001/jama.2012.65406.Long-term use of aspirin and age-related macular degeneration. Klein BE, Howard KP, Gangnon RE, Dreyer JO, Lee KE, Klein R.

.